BIT's 17th Annual Congress of International Drug Discovery Science & Technology-China 2019
★ Submission Guideline

1. The organizers of IDDST-China 2019 welcome all abstracts within the scope of the meeting. Submitted abstracts will be reviewed by experts and scheduled for either oral or poster presentation during the congress. Irrelevant or poor-quality abstracts may be rejected.


2. Abstracts may only be submitted online through the congress website. It is advisable to prepare the complete text of your abstract as well as any figures/tables before accessing online abstract submission.


3. Abstracts need to be written in clear English, taking into account the specifications below:

  1. Maximum word count of abstract title: 20 words.
  2. Maximum word count of abstract text: 350 words (adjust in case of tables/figures).
  3. Abstract topics should be selected during the online submission process from the list of predefined topics in order to facilitate abstract review and scheduling.
  4. A minimum of three specific keywords should be added during online submission for indexing of the abstract. The organizing committee of IDDST-China 2019 reserves the right to delete, edit or add keywords in order to achieve uniformity throughout abstract publications.

4. Abstracts will be published exactly as submitted. No editing of abstract texts will be done. However, failure to comply with the above guidelines may be corrected (e.g. keywords) by the meeting organizers.


5. After submission abstracts can no longer be changed by the authors. Should minor changes be necessary after submission, the author should notify us at jessica@iddst-china.com describing exactly the nature of the change to be made. If major changes are required the author should submit a revised abstract as an entirely new abstract and send a request to jessica@iddst-china.com to delete the original abstract. The addition of a co-author constitutes a major change.


6. After completion of the abstract review, the submitting author will receive scheduling information via email. Abstracts cannot be withdrawn after receipt of the scheduling information by the submitting author. The presenting author must be registered as a participant of IDDST-China 2019 for final scheduling and publication of the abstract.


7. Accepted abstracts will be published in the Conference Proceedings. The authors of the submitted abstracts are responsible for any Intellectual Property issues concerning the abstracts on their own. The organizing committee of IDDST-China 2019 reserves the right to use submitted abstracts for conference purposes.

Online Registration
Hosting Organizations
Foreign Talent Research Center, MOST

Nanjing Municipal Investment Promotion Bureau

Nanjing Municipal Science and Technology Bureau

District People's Government of Jiangning Nanjing

China Biopharma Parks Cluster Alliance

Jiangsu Pharmaceutical Association
Operating Organizations
China Pharmaceutical University

Nanjing Medical University

Nanjing University of Posts and Telecommunications

Administration Committee of Nanjing Jiangning Hi-Tech Development Zone

Information Research Center of International Talent, State Administration of Foreign Experts Affairs, China
Supporting Organizations
China Association for Technology Innovation

Jiangsu Drug Research and Development Association

Editorial Board of Progress in Pharmaceutical Sciences

Journal of Pharmaceutical and Clinical Research

GenScript Biotechnology Co.,Ltd
Executing Organizations
Nanjing U-FOX Congress Inc.

BIT Congress Inc.
Exhibitors


GenScript Biotechnology Co.,Ltd.



Molnar-Institute for applied chromatography



Chengdu Jian River Pharmaceuticals Co.,Ltd.



Anhui General Biosystems Co.,Ltd.



Molecular Devices, LLC.



Crown Bioscience Inc.
Media Partners

BIT's Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.